The estimated Net Worth of Kim R Tsuchimoto is at least $418 mil dollars as of 30 June 2024. Ms Tsuchimoto owns over 9,957 units of Monopar Therapeutics Inc stock worth over $145,025 and over the last 5 years she sold MNPR stock worth over $0. In addition, she makes $273,284 as CFO e Sec. & Treasurer at Monopar Therapeutics Inc.
Sign up
Ms CPA MNPR stock SEC Form 4 insiders trading
Ms has made over 16 trades of the Monopar Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 9,957 units of MNPR stock worth $23,897 on 30 June 2024.
The largest trade she's ever made was exercising 14,846 units of Monopar Therapeutics Inc stock on 30 June 2023 worth over $35,630. On average, Ms trades about 4,507 units every 83 days since 2019. As of 30 June 2024 she still owns at least 60,427 units of Monopar Therapeutics Inc stock.
You can see the complete history of Ms Tsuchimoto stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Kim R. Tsuchimoto CPA biography
Kim R. Tsuchimoto CPA is the CFO, Sec. & Treasurer at Monopar Therapeutics Inc.
What is the salary of Ms CPA?
As the CFO e Sec. & Treasurer of Monopar Therapeutics Inc, the total compensation of Ms CPA at Monopar Therapeutics Inc is $273,284. There are 2 executives at Monopar Therapeutics Inc getting paid more, with Dr. Chandler D. Robinson M.B.A., M.Sc., MBA, M.D., MSc having the highest compensation of $602,888.
How old is Ms CPA?
Ms CPA is 58, she's been the CFO e Sec. & Treasurer of Monopar Therapeutics Inc since . There are 3 older and 3 younger executives at Monopar Therapeutics Inc. The oldest executive at Monopar Therapeutics Inc is Dr. Patrice P. Rioux M.D., Ph.D., 70, who is the Acting Chief Medical Officer.
What's Ms CPA's mailing address?
Kim's mailing address filed with the SEC is 1000 SKOKIE BLVD SUITE 350, , WILMETTE, IL, 60091.
Insiders trading at Monopar Therapeutics Inc
Over the last 5 years, insiders at Monopar Therapeutics Inc have traded over $1,830,000 worth of Monopar Therapeutics Inc stock and bought 895,199 units worth $6,154,669 . The most active insiders traders include Michael J Brown, Diane Hendricks, ePharma Llc Mazar Andrew Pau.... On average, Monopar Therapeutics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $32,266. The most recent stock trade was executed by Andrew Cittadine on 30 June 2024, trading 8,952 units of MNPR stock currently worth $21,485.
What does Monopar Therapeutics Inc do?
monopar therapeutics inc., a biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the united states. it is involved in developing validive, a clonidine mucobuccal tablet that is in phase iii for the treatment of radiation induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin, a topoisomerase ii-alpha targeted analog of doxorubicin engineered to retain anticancer activity and for minimizing toxic effects on the heart; and mnpr-101, a humanized monoclonal antibody for treating advanced solid cancers. the company has a collaboration grupo espaã±ol de investigaciã³n en sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; and northstar medical radioisotopes, llc to develop radio-immuno-therapeutics targeting severe covid-19. monopar therapeutics inc. was founded in 2014 and is headquartered in wilmette, illinois.
What does Monopar Therapeutics Inc's logo look like?
Complete history of Ms Tsuchimoto stock trades at Monopar Therapeutics Inc
Monopar Therapeutics Inc executives and stock owners
Monopar Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Dr. Chandler D. Robinson M.B.A., M.Sc., MBA, M.D., MSc,
Co-Founder, CEO, Pres & Director -
Dr. Andrew P. Mazar,
Exec. VP of R&D, Chief Scientific Officer and Director -
Kim R. Tsuchimoto CPA,
CFO, Sec. & Treasurer -
Kim R. Tsuchimoto,
CFO, Sec. & Treasurer -
Andrew J. Cittadine M.B.A.,
Chief Operating Officer -
Dr. Patrice P. Rioux M.D., Ph.D.,
Acting Chief Medical Officer -
Andrew Cittadine M.B.A.,
Chief Operating Officer -
Dr. Patrice P. Rioux,
Acting Chief Medical Officer -
Raymond Anderson,
Director -
Diane Hendricks,
-
Arthur J Klausner,
Director -
Karl Leo,
-
Pharma Llc Mazar Andrew Pau...,
Chief Scientific OfficerChief Executive Officer -
Patrice Rioux,
-
Michael J Brown,
Director -
Christopher M Starr,
Director -
Chandler Robinson,
Chief Executive Officer -
Kim R Tsuchimoto,
Chief Financial Officer -
Andrew Cittadine,
Chief Operating Officer -
Karthik Radhakrishnan,
Chief Financial Officer